FDA approves Tukysa for advanced, unresectable or metastatic HER2-positive breast cancer April 20, 2020 No Comments
Pemazyre approved in U.S. for advanced cholangiocarcinoma with FGFR2 fusions or rearrangements April 20, 2020 No Comments
Koselugo receives FDA approval for pediatric patients with NF1-related plexiform neurofibromas April 14, 2020 No Comments
FDA approves Braftovi for metastatic colorectal cancer with BRAF V600E mutation April 9, 2020 No Comments
RSS